44826 Federal Register / Vol. 82, No. 185 / Tuesday, September 26, 2017 / Notices 

Place: Gaylord National Resort and 

Convention Center, 201 Waterfront Street, 

National Harbor, MD 20745. 

Contact Person: Gabriel B Fosu, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3108, 

MSC 7808, Bethesda, MD 20892, (301) 435– 

3562, fosug@csr.nih.gov. 

Name of Committee: Biobehavioral and 

Behavioral Processes Integrated Review 

Group; Child Psychopathology and 

Developmental Disabilities Study Section. 

Date: October 19–20, 2017. 

Time: 8:00 p.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Gaylord National Resort and 

Convention Center, 201 Waterfront Street, 

National Harbor, MD 20745. 

Contact Person: Jane A DoussardRoosevelt, Ph.D., Scientific Review Officer, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Room 3184, MSC 7848, Bethesda, MD 20892, 

(301) 435–4445, doussarj@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Interventions and Mechanisms for 

Addiction. 

Date: October 19, 2017. 

Time: 12:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Marc Boulay, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3110, 

MSC 7808, Bethesda, MD 20892, (301) 300– 

6541, boulaymg@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Risk Prevention and Social 

Behavior. 

Date: October 19, 2017. 

Time: 12:00 p.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Weijia Ni, Ph.D., Chief/ 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3100, 

MSC 7808, Bethesda, MD 20892, 301–594– 

3292, niw@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Child Psychopathology and 

Developmental Disabilities. 

Date: October 19, 2017. 

Time: 12:30 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Serena Chu, Ph.D., 

Scientific Review Officer, BBBP IRG, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3178, 

MSC 7848, Bethesda, MD 20892, 301–500– 

5829, sechu@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: September 20, 2017. 

David Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–20485 Filed 9–25–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Heart, Lung, 

and Blood Advisory Council. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Advisory Council. 

Date: October 24, 2017. 

Open: 8:00 a.m. to 12:00 p.m. 

Agenda: To discuss program policies and 

issues. 

Place: National Institutes of Health, 

Building 35A, Porter Building, 35A Convent 

Drive, Room 640, Bethesda, MD 20892. 

Closed: 12:30 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Building 35A, Porter Building, 35A Convent 

Drive, Room 640, Bethesda, MD 20892. 

Contact Person: Laura K. Moen, Ph.D., 

Director, Division of Extramural Research 

Activities National Heart, Lung, and Blood 

Institute National Institutes of Health, 6701 

Rockledge Drive, Room 7100, Bethesda, MD 

20892, 301–435–0260, moenl@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: 

www.nhlbi.nih.gov/meetings/nhlbac/ 

index.htm, where an agenda and any 

additional information for the meeting will 

be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: September 20, 2017. 

Michelle Trout, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–20491 Filed 9–25–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings of the NHLBI 

Special Emphasis Panel. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

CLTR Conflicts Meeting. 

Date: October 26, 2017. 

Time: 8:30 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Federal Register / Vol. 82, No. 185 / Tuesday, September 26, 2017 / Notices 44827 

Place: The William F. Bolger Center, 9600 

Newbridge Drive, Potomac, MD 20854. 

Contact Person: YingYing Li-Smerin, MD, 

Ph.D., Scientific Review Officer, Office of 

Scientific Review/DERA, National Heart, 

Lung, and Blood Institute, 6701 Rockledge 

Drive, Room 7184, Bethesda, MD 20892– 

7924, 301–827–7942, lismerin@nhlbi.nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Clinical Trial Pilot Studies (R34). 

Date: October 26–27, 2017. 

Time: 1:00 p.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The William F. Bolger Center, 9600 

Newbridge Drive, Potomac, MD 20854. 

Contact Person: YingYing Li-Smerin, MD, 

Ph.D., Scientific Review Officer, Office of 

Scientific Review/DERA, National Heart, 

Lung, and Blood Institute, 6701 Rockledge 

Drive, Room 7184, Bethesda, MD 20892– 

7924, 301–827–7942, lismerin@nhlbi.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: September 20, 2017. 

Michelle Trout, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–20490 Filed 9–25–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[Docket No. USCG–2017–0747] 

Boston Area Maritime Security 

Advisory Committee; Vacancies 

AGENCY: Coast Guard, Department of 

Homeland Security. 

ACTION: Request for applications. 

SUMMARY: This notice requests 

individuals interested in serving on the 

Boston Area Maritime Security 

Committee (AMSC) to submit their 

applications for membership, to the 

Captain of the Port (COTP), Boston, MA. 

DATES: Requests for membership should 

reach the U.S. Coast Guard COTP 

Boston October 26, 2017. 

ADDRESSES: Applications for 

membership should be submitted to the 

Captain of the Port Boston at the 

following address: Commander (sx), 

USCG Sector Boston, 427 Commercial 

Street, Boston, MA 02109 or by email to 

Phillip.C.Smith@uscg.mil. 

FOR FURTHER INFORMATION CONTACT: For 

questions about submitting an 

application or about the AMSC in 

general, contact Mr. Phillip C. Smith at 

617–223–3008 or by email to 

Phillip.C.Smith@uscg.mil. 

SUPPLEMENTARY INFORMATION: 

Authority 

Section 102 of the Maritime 

Transportation Security Act (MTSA) of 

2002 (Pub. L. 107–295) added section 

70112 to Title 46 of the U.S. Code, and 

authorized the Secretary of the 

Department in which the Coast Guard is 

operating to establish Area Maritime 

Security Advisory Committees for any 

port area of the United States. (See 33 

U.S.C. 1226, 1231; 46 U.S.C. chapter 

701; 50 U.S.C. 191, 192; 33 CFR 1.05– 

1, 6.01; Department of Homeland 

Security Delegation No. 0170.1). Under 

46 U.S.C. 70112(g)(1)(B), the Federal 

Advisory Committee Act (FACA) does 

not apply to AMSCs. 

Boston AMSC Purpose 

The AMSCs shall assist the Captain of 

the Port in the development, review, 

update, and exercise of the AMS Plan 

for their area of responsibility. Such 

matters may include, but are not limited 

to: Identifying critical port 

infrastructure and operations; 

Identifying risks (threats, 

vulnerabilities, and consequences); 

Determining mitigation strategies and 

implementation methods; Developing 

strategies to facilitate the recovery of the 

MTS after a Transportation Security 

Incident; Developing and describing the 

process to continually evaluate overall 

port security by considering 

consequences and vulnerabilities, how 

they may change over time, and what 

additional mitigation strategies can be 

applied. 

AMSC Composition 

The composition of an AMSC, to 

include the Boston AMSC, is prescribed 

under 33 CFR 103.305. Pursuant to that 

regulation, members may be selected 

from the Federal, Territorial, or Tribal 

government; the State government and 

political subdivisions of the State; local 

public safety, crisis management, and 

emergency response agencies; law 

enforcement and security organizations; 

maritime industry, including labor; 

other port stakeholders having a special 

competence in maritime security; and 

port stakeholders affect by security 

practices and policies. Also, at least 7 of 

the AMSC members must each have 5 

or more years of experience related to 

maritime or port security operations. 

AMSC Membership 

The Boston AMSC has 41 members 

who represent Federal, State, local, and 

industry stakeholders from 

Massachusetts. We are seeking to fill 11 

positions with this solicitation. 

Applicants may be required to pass an 

appropriate security background check 

prior to appointment to the committee. 

Members’ terms of office will be for 5 

years; however, a member is eligible to 

serve additional terms of office. 

Members will not receive any salary or 

other compensation for their service on 

an AMSC. 

Request for Applications 

Those seeking membership are not 

required to submit formal applications 

to the local Captain of the Port, 

however, because we do have an 

obligation to ensure that a specific 

number of members have the 

prerequisite maritime security 

experience, we encourage the 

submission of resumes highlighting 

experience in the maritime and security 

industries. 

The Department of Homeland 

Security does not discriminate in 

selection of Committee members on the 

basis of race, color, religion, sex, 

national origin, political affiliation, 

sexual orientation, gender identity, 

marital status, disability and genetic 

information, age, membership in an 

employee organization, or other nonmerit factor. The Department of 

Homeland Security strives to achieve a 

widely diverse candidate pool for all of 

its recruitment actions. 

Dated: September 19, 2017. 

C.C. Gelzer, 

Captain, U.S. Coast Guard, Federal Maritime 

Security Coordinator Boston. 

[FR Doc. 2017–20483 Filed 9–25–17; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HOMELAND 

SECURITY 

Federal Emergency Management 

Agency 

[Internal Agency Docket No. FEMA–3387– 

EM; Docket ID FEMA–2017–0001] 

Georgia; Amendment No. 2 to Notice of 

an Emergency Declaration 

AGENCY: Federal Emergency 

Management Agency, DHS. 

ACTION: Notice. 

SUMMARY: This notice amends the notice 

of an emergency declaration for the 

State of Georgia (FEMA–3387–EM), 

dated September 8, 2017, and related 

determinations. 

DATES: This amendment was issued 

September 11, 2017. 

FOR FURTHER INFORMATION CONTACT: 

Dean Webster, Office of Response and